Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. SL Kunkel, M Spengler, MA May, R Spengler, J Larrick, D Remick Journal of Biological Chemistry 263 (11), 5380-5384, 1988 | 835 | 1988 |
Competitive PCR. P Siebert, JW Larrick Nature 359 (6395), 1992 | 834 | 1992 |
Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline RM Strieter, DG Remick, PA Ward, RN Spengler, JP Lynch Iii, J Larrick, ... Biochemical and biophysical research communications 155 (3), 1230-1236, 1988 | 747 | 1988 |
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein JW Larrick, M Hirata, RF Balint, J Lee, J Zhong, SC Wright Infection and immunity 63 (4), 1291-1297, 1995 | 743 | 1995 |
Cytotoxic mechanism of tumor necrosis factor‐α JW Larrick, SC Wright The FASEB journal 4 (14), 3215-3223, 1990 | 698 | 1990 |
Tumor necrosis factor causes increased pulmonary permeability and edema KE Stephens, A Ishizaka, JW Larrick, TA Raffin Am Rev Respir Dis 137 (6), 1364-70, 1988 | 491 | 1988 |
Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages PR Bachwich, SW Chensue, JW Larrick, SL Kunkel Biochemical and biophysical research communications 136 (1), 94-101, 1986 | 468 | 1986 |
PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. PD Siebert, JW Larrick Biotechniques 14 (2), 244-249, 1993 | 467 | 1993 |
Modulation of cell surface iron transferrin receptors by cellular density and state of activation JW Larrick, P Cresswell Journal of supramolecular structure 11 (4), 579-586, 1979 | 450 | 1979 |
Regulation of macrophage tumor necrosis factor production by prostaglandin E2 SL Kunkel, RC Wiggins, SW Chensue, J Larrick Biochemical and biophysical research communications 137 (1), 404-410, 1986 | 395 | 1986 |
Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. RL Berkow, D Wang, JW Larrick, RW Dodson, TH Howard Journal of immunology (Baltimore, Md.: 1950) 139 (11), 3783-3791, 1987 | 372 | 1987 |
Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. CA Brenner, AW Tam, PA Nelson, EG Engleman, N Suzuki, KE Fry, ... Biotechniques 7 (10), 1096-1103, 1989 | 358 | 1989 |
Acute in vivo effects of human recombinant tumor necrosis factor. DG Remick, RG Kunkel, JW Larrick, SL Kunkel Laboratory investigation; a journal of technical methods and pathology 56 (6 …, 1987 | 356 | 1987 |
Antibody engineering at the millennium JV Gavilondo, JW Larrick Biotechniques 29 (1), 128-145, 2000 | 315 | 2000 |
Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus N Balaban, T Goldkorn, RT Nhan, LB Dang, S Scott, RM Ridgley, ... Science 280 (5362), 438-440, 1998 | 300 | 1998 |
Producing proteins in transgenic plants and animals JW Larrick, DW Thomas Current opinion in biotechnology 12 (4), 411-418, 2001 | 299 | 2001 |
Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells using mixed primers and the polymerase chain reaction JW Larrick, L Danielsson, CA Brenner, M Abrahamson, KE Fry, ... Biochemical and biophysical research communications 160 (3), 1250-1256, 1989 | 276 | 1989 |
Inhibition of apoptosis as a mechanism of tumor promotion SC Wright, J Zhong, JW Larrick The FASEB journal 8 (9), 654-660, 1994 | 266 | 1994 |
Antibody engineering by parsimonious mutagenesis RF Balint, JW Larrick Gene 137 (1), 109-118, 1993 | 259 | 1993 |
Characterization of a human macrophage-like cell line stimulated in vitro: a model of macrophage functions. JW Larrick, DG Fischer, SJ Anderson, HS Koren Journal of immunology (Baltimore, Md.: 1950) 125 (1), 6-12, 1980 | 251 | 1980 |